PYXIS ONCOLOGY INC (PYXS)
US7473241013 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 12.06M | 9.66M | 179.30M | 274.70M | 8.10M | |||
| Marketable Securities | 132.76M | 109.63M | N/A | N/A | N/A | |||
| Receivables | N/A | 21.00K | 600.00K | N/A | N/A | |||
| Other Current Assets | 4.05M | 5.29M | 6.80M | 4.00M | 0.00 | |||
| Total Current Assets | 148.87M | 124.60M | 186.60M | 278.70M | 8.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 22.82M | 24.81M | 24.80M | 1.20M | 1.90M | |||
| Intangibles | 23.62M | 24.31M | N/A | N/A | N/A | |||
| Other Non-Current Assets | N/A | N/A | 0.00 | 100.00K | 100.00K | |||
| Total Non-Current Assets | 46.44M | 49.12M | 24.80M | 1.30M | 2.10M | |||
| TOTAL ASSETS | 195.31M | 173.73M | 211.40M | 280.00M | 10.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 15.45M | 13.85M | 23.40M | 6.50M | 1.60M | |||
| Accounts Payable | 4.87M | 3.90M | 7.10M | 12.00M | 1.10M | |||
| Other Current Liabilities | 0.00 | 8.02M | 1.10M | 300.00K | 1.00M | |||
| Total Current Liabilities | 20.32M | 25.76M | 31.60M | 18.70M | 3.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 117.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 2.16M | 2.16M | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 19.03M | 20.10M | 18.90M | 0.00 | 200.00K | |||
| Total Non-Current Liabilities | 21.31M | 22.26M | 19.00M | 0.00 | 200.00K | |||
| TOTAL LIABILITIES | 41.63M | 48.02M | 50.60M | 18.70M | 3.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -327.99M | -286.23M | -212.40M | -91.70M | -15.70M | |||
| Additional Paid In Capital | 481.25M | 411.82M | 373.20M | 353.00M | 100.00K | |||
| Common Shares | 59.00K | 45.00K | 0.00 | 0.00 | 21.90M | |||
| Other Shareholders' Equity | 351.00K | 63.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 59.45M | 44.75M | 35.10M | 32.20M | 32.70M | |||
| Tangible Book Value per Share | 2.19 | 2.27 | 4.58 | 8.11 | -0.48 | |||
| Total Shareholders' Equity | 153.68M | 125.70M | 160.80M | 261.30M | 6.30M | |||
| TOTAL LIABILITIES AND EQUITY | 195.31M | 173.73M | 211.40M | 280.00M | 10.20M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 7.33 | 4.84 | 5.91 | 14.90 | 2.19 | |||
| Return On Assets (ROA) | -29.37% | -42.47% | -57.11% | -27.14% | -125.78% | |||
| Return On Equity (ROE) | -37.32% | -58.70% | -75.07% | -29.08% | -203.65% | |||
All data in USD , ROIC based on taxRate of 0.21